T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.86% |
| 2 | Healthcare | 16.8% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Technology | 13.29% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Annaly Capital Management
NLY
$17.6B
| $4.58M | ﹤0.01% |
114,827
+12,629
| +12% | +$514K |
|
|
CDK
1427
DELISTED
CDK Global, Inc.
CDK
| $4.51M | ﹤0.01% |
75,613
+1,215
| +2% | +$69.5K |
|
1428
Autoliv
ALV
$8.89B
| $4.39M | ﹤0.01% |
53,910
-2,082
| -4% | -$155K |
|
1429
Ingredion
INGR
$6.63B
| $4.33M | ﹤0.01% |
34,660
-1,433,326
| -98% | -$181M |
|
1430
Cartesian Therapeutics
RNAC
$264M
| $4.26M | ﹤0.01% |
+8,280
| New | +$4.84M |
|
|
SRCI
1431
DELISTED
SRC Energy Inc
SRCI
| $4.22M | ﹤0.01% |
473,359
-4,289,470
| -90% | -$35M |
|
|
SUPV
1432
Grupo Supervielle
SUPV
$738M
| $4.21M | ﹤0.01% |
320,400
-6,600
| -2% | -$94.5K |
|
1433
ResMed
RMD
$32.9B
| $4.2M | ﹤0.01% |
67,754
+8,688
| +15% | +$532K |
|
|
TPH
1434
DELISTED
Tri Pointe Homes
TPH
| $4.15M | ﹤0.01% |
361,510
-470,050
| -57% | -$5.62M |
|
1435
Rigel Pharmaceuticals
RIGL
$762M
| $4.08M | ﹤0.01% |
171,403
+73,966
| +76% | +$2.12M |
|
|
FLG
1436
Flagstar Bank National Association
FLG
$5.92B
| $4.07M | ﹤0.01% |
85,238
+16,567
| +24% | +$758K |
|
1437
Ameris Bancorp
ABCB
$6B
| $4.04M | ﹤0.01% |
92,595
| – | – |
|
1438
Lear
LEA
$8.16B
| $4.02M | ﹤0.01% |
30,343
+484
| +2% | +$60.9K |
|
|
EV
1439
DELISTED
Eaton Vance Corp.
EV
| $3.96M | ﹤0.01% |
94,552
+7
| +0% | +$275 |
|
|
GNMX
1440
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $3.94M | ﹤0.01% |
760,167
-3,700
| -0.5% | -$19.5K |
|
1441
Hyster-Yale Materials Handling
HY
$617M
| $3.94M | ﹤0.01% |
61,714
-5,120
| -8% | -$315K |
|
|
MBT
1442
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $3.81M | ﹤0.01% |
417,900
+379,100
| +977% | +$3.05M |
|
1443
Cedar Fair
FUN
$1.71B
| $3.75M | ﹤0.01% |
58,460
-166
| -0.3% | -$9.96K |
|
1444
Everest Group
EG
$14B
| $3.75M | ﹤0.01% |
17,324
-734
| -4% | -$151K |
|
1445
Wave Life Sciences
WVE
$1.02B
| $3.72M | ﹤0.01% |
142,220
-100
| -0.1% | -$3.25K |
|
|
CETV
1446
DELISTED
Central European Media Enterprises Ltd
CETV
| $3.72M | ﹤0.01% |
1,457,900
| – | – |
|
1447
Ares Capital
ARCC
$14.5B
| $3.71M | ﹤0.01% |
225,000
| – | – |
|
|
CIT
1448
DELISTED
CIT Group Inc.
CIT
| $3.66M | ﹤0.01% |
85,780
-1,216
| -1% | -$47.9K |
|
1449
Synopsys
SNPS
$78.8B
| $3.65M | ﹤0.01% |
62,094
+644
| +1% | +$38.3K |
|
1450
ICICI Bank
IBN
$106B
| $3.65M | ﹤0.01% |
536,279
-39,192
| -7% | -$279K |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.